– USA, FL – Akumin Inc. (NASDAQ: AKU | TSX: AKU) today announced the appointments of John Wagner and Lawrence Ross Sinclair to its board of directors, effective January 1, 2023.
“We have strengthened our board of directors with the addition of John Wagner, who represents a long-term shareholder that believes in our strategic direction and continues to support the future value creation of our asset base, and Ross Sinclair, who brings significant audit and financial reporting experience,” said Chairman and CEO, Riadh Zine.
Mr. Sinclair will also join the audit committee effective January 1, 2023.
Mr. Wagner is a nominee of SCW Capital Management, LP, which through its affiliates currently holds an approximate 12.7% interest in the common stock of Akumin.
About John Wagner
John Wagner is a co-founder and co-managing partner of SCW Capital which is an equity investment fund focused on domestic public equities where he focuses on the healthcare technology and service sectors (2014-present). In addition to SCW Capital, Mr. Wagner is the co-founder and Managing Partner for Viewside Capital Partners. Viewside Capital Partners is a private equity firm focused on growth equity investments in the healthcare technology and service sectors. Mr. Wagner is currently a member of the board of directors for D2 Solutions, Benefit Harbor, Strivant Health, and Flow Therapy. Before his current roles, Mr. Wagner was the CFO of Healthcare Payment Specialists, a private equity-owned healthcare IT company (2012-2013), a Partner with Walker Smith Capital responsible for investments within the healthcare industry (2003-2012), an Associate in the Healthcare Investment Banking Group at UBS and an Analyst in the Healthcare Corporate Finance Group at Bank of America (1999-2003).
Mr. Wagner graduated from the University of Texas with a Bachelor of Business Administration in Finance.
About Lawrence Ross Sinclair
Mr. Sinclair was a partner with PricewaterhouseCoopers LLP and has more than 25 years of experience as a partner. He retired from PwC on June 30, 2020, and has worked since July 2021 as a Senior Financial Consultant for the Real Estate Group of Fengate Asset Management and a Trustee with Enterprise REIT since March 2022. Mr. Sinclair has had extensive experience across several industries including consumer products, retail, real estate, health care ,and private equity. He has worked advising on critical business issues, transactions, and restructurings in addition to his experience as a lead audit partner on both public and private enterprises. Mr. Sinclair’s experience includes PwC Canada leadership roles as Income Trust and IPO Services Group Leader. He has significant experience working with clients on their capital markets projects and needs including numerous equity, debt ,and initial public offering and RTOs. In addition to serving as the audit partner on many public companies across various reporting frameworks including US GAAP, and IFRS, Mr. Sinclair was a designated Trustee on the Continuum REIT IPO in the fall of 2019, a director of Nova Cannabis Inc from its March 2021 RTO to April 2022 and is an Advisory Board member and investor in Arch Corporation.
Mr. Sinclair graduated from the University of Toronto with a Bachelor of Commerce and is a Chartered Professional Accountant.
About Akumin
Akumin is a national partner of choice for U.S. hospitals, health systems, and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs. Akumin provides (1) fixed-site outpatient diagnostic imaging services through a network of owned and/or operated imaging locations; and (2) outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across 48 states. By combining clinical and operational expertise with the latest advances in technology and information systems, Akumin facilitates more efficient and effective diagnosis and treatment for patients and their providers. Akumin’s imaging procedures include MRI, CT, positron emission tomography, ultrasound, diagnostic radiology, mammography, and other interventional procedures; our cancer care services include a full suite of radiation therapy and related offerings.
For more information: https://akumin.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.